Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TOT Biopharm

TOT Biopharm
2010 FOUNDED
PUBLIC STATUS
301-400 EMPLOYEES
01875 STOCK SYMBOL
$0.49 SHARE PRICE (As of Friday Closing)
Description

TOT Biopharm International Co Ltd p is engaged in the research, development and licensing of self-developed biological drug.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
HKG
Primary Office
  • 120 Changyang Street
  • Suzhou Industrial Park
  • Suzhou, 215024
  • China

+86 0512 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TOT Biopharm’s full profile, request a free trial.

TOT Biopharm Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.48 - $0.82 $278M $0.49 -$0.07 270K 570M

TOT Biopharm Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
Revenue 5,929 5,929 7,637
EBITDA (37,932) (37,932) (20,034)
Net Income (40,552) (40,552) (22,002)
Total Assets 98,450 98,450 55,763
Total Debt 2,272 2,272 41,170
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TOT Biopharm Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore TOT Biopharm‘s full profile, request access.

Request full access to PitchBook

TOT Biopharm Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore TOT Biopharm‘s full profile, request access.

Request full access to PitchBook

TOT Biopharm Board Members (1)

Name Representing Role Since Contact
Info
Rongjin Lin TOT Biopharm Chairman 000 0000